Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 54.84

+0.2%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who started this subject	4/27/2002 7:47:06 PM
From: Robohogs	Read Replies (1) of 52153

Interesting table from thestreet.com on public site - only reason willing to post data and not link. A Date With Expiration Here's a sampling of big-selling drugs whose patents will expire between 2002 and 2005 Expiration Date Drug Name Brand-Name Maker Indication April 2002 Axid Eli Lilly Gastrointestinal December 2002 Claritin Schering-Plough Allergy December 2002 Augmentin GlaxoSmithKline Infection December 2002 Intron A ICN Pharmaceuticals Hepatitis-C December 2002 Relafen GlaxoSmithKline Arthritis February 2003 Singulair Merck Asthma November 2003 Flovent GlaxoSmithKline Asthma November 2003 Flonase GlaxoSmithKline Allergy November 2003 Cipro Bayer Infection December 2003 Engerix-B GlaxoSmithKline Hepatitis-B January 2004 Diflucan Pfizer Infection April 2004 Paraplatin Bristol-Myers Squibb Cancer June 2004 Xenical Roche Obesity July 2004 Lamisil Novartis Tenia Pedis August 2004 Wellbutrin GlaxoSmithKline Depression October 2004 Lupron TAP Pharmaceuticals Cancer December 2004 Lovenox Aventis Deep-Vein Thrombosis Source: Business for Affordable Medicine, TSC Research PS How do I make it look pretty? Jon

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next